Therefore, we investigated MFN2 mRNA expression in tumor and adjacent non-tumor tissues from 115 patients with HCC and statistically evaluated the association of MFN2 mRNA expression with clinical and pathological parameters. This evidence concerns the gene MFN2 and hepatocellular carcinoma.